Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Albireo Pharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Albireo Pharma Inc market cap is $915.89M.
What is the 52-week high for Albireo Pharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Albireo Pharma Inc 52 week high is $45.23 as of September 11, 2025.
What is the 52-week low for Albireo Pharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Albireo Pharma Inc 52 week low is $16.02 as of September 11, 2025.
What is Albireo Pharma Inc stock price today?
Albireo Pharma Inc stock price today is $44.36.
What was Albireo Pharma Inc stock price yesterday?
Albireo Pharma Inc stock price yesterday was $44.25.
What is the PE ratio of Albireo Pharma Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Albireo Pharma Inc’s P/E ratio is -6.57.
What is the Price-to-Book ratio of Albireo Pharma Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Albireo Pharma Inc P/B ratio is 9.1294.
What is the 50-day moving average of Albireo Pharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Albireo Pharma Inc 50-day moving average is $37.97.